Hideaki Nakajima

13.0k total citations · 3 hit papers
268 papers, 8.2k citations indexed

About

Hideaki Nakajima is a scholar working on Hematology, Molecular Biology and Immunology. According to data from OpenAlex, Hideaki Nakajima has authored 268 papers receiving a total of 8.2k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Hematology, 68 papers in Molecular Biology and 52 papers in Immunology. Recurrent topics in Hideaki Nakajima's work include Acute Myeloid Leukemia Research (49 papers), Immune Cell Function and Interaction (25 papers) and Hematopoietic Stem Cell Transplantation (21 papers). Hideaki Nakajima is often cited by papers focused on Acute Myeloid Leukemia Research (49 papers), Immune Cell Function and Interaction (25 papers) and Hematopoietic Stem Cell Transplantation (21 papers). Hideaki Nakajima collaborates with scholars based in Japan, United States and United Kingdom. Hideaki Nakajima's co-authors include Toshio Kitamura, Tetsuya Nosaka, Hidetoshi Kumagai, Fumi Shibata, Toshihiko Oki, Yumi Fukuchi, Itaru Honma, S. Nomura, Kohichiro Tsuji and Daisuke Sugiyama and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Circulation.

In The Last Decade

Hideaki Nakajima

258 papers receiving 8.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Retrovirus-mediated gene transfer and expression cloning: powerful tools in functional genomics

2003 591 citations Toshio Kitamura, Hideaki Nakajima et al. Experimental Hematology profile →
Retrovirus-mediated gene transfer and expression cloning: powerful tools in functional genomics

2003 560 citations Toshio Kitamura, Hideaki Nakajima et al. Experimental Hematology profile →
Human Placenta‐Derived Cells Have Mesenchymal Stem/Progenitor Cell Potential

2004 502 citations Hideaki Nakajima, Toshio Kitamura et al. profile →

Peers

Countries citing papers authored by Hideaki Nakajima

Since Specialization

Citations

This map shows the geographic impact of Hideaki Nakajima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideaki Nakajima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideaki Nakajima more than expected).

Fields of papers citing papers by Hideaki Nakajima

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideaki Nakajima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideaki Nakajima. The network helps show where Hideaki Nakajima may publish in the future.

Co-authorship network of co-authors of Hideaki Nakajima

This figure shows the co-authorship network connecting the top 25 collaborators of Hideaki Nakajima. A scholar is included among the top collaborators of Hideaki Nakajima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideaki Nakajima. Hideaki Nakajima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinical applicability of the ELN2020 criteria for tyrosine kinase inhibitor discontinuation in chronic myeloid leukemia: insights from a multicenter retrospective study in real-world practice 2025 ·Leukemia Research ·(unknown), Shin Fujisawa, Katsumichi Fujimaki, Maki Hagihara, Hiroyuki Fujita, Masatsugu Tanaka, (unknown), Takaaki Takeda, (unknown), (unknown), Yoshimi Ishii, Yuki Nakajima, Takuya Miyazaki, Hideaki Nakajima	0
2	Successful re-administration of tocilizumab in a patient with adult-onset Still’s disease after improvement of macrophage activation syndrome 2025 ·Modern Rheumatology Case Reports ·Yutaka Nagasawa, Kaoru Takase-Minegishi, (unknown), (unknown), (unknown), Tomoya Watanabe, Yukie Yamaguchi, (unknown), Yohei Kirino, Hideaki Nakajima	0
3	Targeting enhanced cell death represents a potential therapeutic strategy for VEXAS syndrome 2024 ·Rheumatology Advances in Practice ·(unknown), Yohei Kirino, (unknown), (unknown), Ayaka Maeda, Nobuyuki Horita, Kaoru Takase-Minegishi, Ryusuke Yoshimi, Hideaki Nakajima	8
4	Integrin β2 regulates titanium particle‑induced inflammation in macrophages: In vitro aseptic loosening model 2024 ·Molecular Medicine Reports ·Yue Shen, Hideaki Nakajima, Junfeng Zhu, Weigang Wu	1
5	Pregnancy outcomes in patients with familial Mediterranean fever: systematic review and meta-analysis 2023 ·Lara D. Veeken ·(unknown), Midori Yamaguchi, Kaoru Takase‐Minegishi, Yohei Kirino, Shigeru Aoki, (unknown), (unknown), (unknown), Ayaka Maeda, Naomi Tsuchida, Ryusuke Yoshimi, Nobuyuki Horita, Hideaki Nakajima, (unknown)	4
6	Successful treatment with lenalidomide for relapsed adult T-cell leukemia/lymphoma after cord blood cell transplantation 2021 ·PubMed ·Katsumichi Fujimaki, (unknown), (unknown), Shinichiro Watanabe, Satoshi Koyama, (unknown), Heiwa Kanamori, Hideaki Nakajima	1
7	O-GlcNAcylation: Implications in normal and malignant hematopoiesis 2021 ·Experimental Hematology ·Hideaki Nakajima, Koichi Murakami	3
8	Beneficial effects of apremilast on genital ulcers, skin lesions, and arthritis in patients with Behçet’s disease: A systematic review and meta-analysis 2021 ·Modern Rheumatology ·(unknown), Kaoru Takase-Minegishi, (unknown), Yohei Kirino, (unknown), Ho Namkoong, Nobuyuki Horita, Ryusuke Yoshimi, Masaki Takeuchi, Mitsuhiro Takeno, Nobuhisa Mizuki, Hideaki Nakajima	7
9	Pathogenic UBA1 variants associated with VEXAS syndrome in Japanese patients with relapsing polychondritis 2021 ·Annals of the Rheumatic Diseases ·Naomi Tsuchida, Yosuke Kunishita, Yuri Uchiyama, Yohei Kirino, (unknown), Yukie Yamaguchi, Masataka Taguri, Shoji Yamanaka, Kaoru Takase‐Minegishi, Ryusuke Yoshimi, Satoshi Fujii, Hideaki Nakajima, Naomichi Matsumoto	82
10	Changes in the proportion of clinical clusters contribute to the phenotypic evolution of Behçet’s disease in Japan 2021 ·Arthritis Research & Therapy ·(unknown), Yohei Kirino, Mitsuhiro Takeno, Michiko Kurosawa, Masaki Takeuchi, Ryusuke Yoshimi, Yumiko Sugiyama, Shigeru Ohno, (unknown), Akiko Sekiguchi, (unknown), (unknown), Yoshiaki Ishigatsubo, Hideaki Nakajima, Nobuhisa Mizuki	43
11	Anti-TRIM21 antibody is associated with aberrant B-cell function and type I interferon production in systemic lupus erythematosus 2021 ·Lupus ·Yosuke Kunishita, Ryusuke Yoshimi, Reikou Kamiyama, Daiga Kishimoto, (unknown), Natsuki Sakurai, Yumiko Sugiyama, Kaoru Takase‐Minegishi, Yohei Kirino, Shouhei Nagaoka, Hideaki Nakajima	7
12	Efficacy and safety of apremilast for 3 months in Behçet’s disease: A prospective observational study 2020 ·Modern Rheumatology ·(unknown), Yohei Kirino, (unknown), Mitsuhiro Takeno, Kaoru Takase-Minegishi, Ryusuke Yoshimi, Masaki Takeuchi, Nobuhisa Mizuki, Hideaki Nakajima	11
13	Elevated serum gasdermin D N-terminal implicates monocyte and macrophage pyroptosis in adult-onset Still's disease 2020 ·Lara D. Veeken ·(unknown), Yohei Kirino, (unknown), Yosuke Kunishita, (unknown), Ann Marie Szymanski, Ryusuke Yoshimi, Michael J. Ombrello, Hideaki Nakajima	16
14	Haploinsufficiency of A20 caused by a novel nonsense variant or entire deletion of TNFAIP3 is clinically distinct from Behçet’s disease 2019 ·Arthritis Research & Therapy ·Naomi Tsuchida, Yohei Kirino, (unknown), Masafumi Onodera, Katsuhiro Arai, (unknown), Takashi Ishikawa, Toshinao Kawai, Toru Uchiyama, Shigeru Nomura, Daisuke Kobayashi, Masataka Taguri, Satomi Mitsuhashi, Takeshi Mizuguchi, Atsushi Takata, Noriko Miyake, Hideaki Nakajima, Satoko Miyatake, Naomichi Matsumoto	43
15	Time-dependent degradation of carbon nanotubes correlates with decreased reactive oxygen species generation in macrophages 2019 ·SHILAP Revista de lepidopterología ·Mengmeng Yang, Minfang Zhang, Hideaki Nakajima, Masako Yudasaka, Sumio Iijima, Toshiya Okazaki	1
16	miR-1 is a novel biomarker for polymyositis/dermatomyositis-associated interstitial lung disease 2019 ·Modern Rheumatology ·Yumiko Sugiyama, Ryusuke Yoshimi, Mitsuhiro Takeno, Yosuke Kunishita, Daiga Kishimoto, Reikou Kamiyama, Yohei Kirino, Shigeru Ohno, Hideaki Nakajima	12
17	Dysfunction of TRIM21 in interferon signature of systemic lupus erythematosus 2018 ·Modern Rheumatology ·Reikou Kamiyama, Ryusuke Yoshimi, Mitsuhiro Takeno, (unknown), Toshinori Tsukahara, Daiga Kishimoto, Yosuke Kunishita, Yumiko Sugiyama, Naomi Tsuchida, (unknown), (unknown), Maasa Tamura, (unknown), Yohei Kirino, Yoshiaki Ishigatsubo, Keiko Ozato, Hideaki Nakajima	14
18	AML1 mutations induced MDS and MDS/AML in a mouse BMT model 2008 ·Blood ·Naoko Watanabe‐Okochi, Jiro Kitaura, Ryoichi Ono, Hironori Harada, Yuka Harada, Yukiko Komeno, Hideaki Nakajima, Tetsuya Nosaka, Toshiya Inaba, Toshio Kitamura	115
19	Dimerization of MLL fusion proteins and FLT3 activation synergize to induce multiple-lineage leukemogenesis 2005 ·Journal of Clinical Investigation ·Ryoichi Ono, Hideaki Nakajima, Katsutoshi Ozaki, Hidetoshi Kumagai, Toshiyuki Kawashima, Tomohiko Taki, Toshio Kitamura, Yasuhide Hayashi, Tetsuya Nosaka	90
20	The Rationale of Managing Hyperuricemia in the Patients with the Socalled Lifestyle Related Disorders : Pitfalls and Limitations of the Proposed Guideline 2000 ·Hideaki Nakajima	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact